Saluda Medical, Inc. (ASX:SLD)
Australia · Delayed Price · Currency is AUD 1.270
-1.380 (-52.08%)
At close: Dec 5, 2025
Saluda Medical Company Description
Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands.
The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window.
It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesota.
Saluda Medical, Inc.
| Country | United States |
| Founded | 2011 |
| Industry | Medical, Dental, and Hospital Equipment and Supplies |
| Employees | 133 |
| CEO | Barry Regan |
Contact Details
Address: 9401 James Avenue S Bloomington, Delaware 55431 United States | |
| Phone | (857) 272-9585 |
| Website | saludamedical.com |
Stock Details
| Ticker Symbol | SLD |
| Exchange | Australian Securities Exchange |
| Reporting Currency | AUD |
| SIC Code | 5047 |
Key Executives
| Name | Position |
|---|---|
| Barry Regan | Chief Executive Officer |
| James Erickson | Chief Financial Officer |
| Greg Plamondon | Chief Operating Officer |